PPARγ against tumors by different signaling pathways.

IF 0.3 4区 医学 Q4 Medicine
Onkologie Pub Date : 2013-01-01 Epub Date: 2013-09-17 DOI:10.1159/000355328
Zhi Zhang, Ying Xu, Qinggang Xu, Yongzhong Hou
{"title":"PPARγ against tumors by different signaling pathways.","authors":"Zhi Zhang,&nbsp;Ying Xu,&nbsp;Qinggang Xu,&nbsp;Yongzhong Hou","doi":"10.1159/000355328","DOIUrl":null,"url":null,"abstract":"<p><p>The peroxisome proliferator-activated receptor-γ (PPARγ) belongs to the nuclear hormone receptor superfamily, and is expressed in adipose tissue, skeletal muscle, spleen, heart, liver, placenta, lung, and ovary. PPARγ is a critical regulator of inflammation, adipocyte differentiation, glucose homeostasis, and tumorigenesis. The mechanism of PPARγ on tumor suppression is still unclear, but plenty of evidence shows that PPARγ provides new therapeutic targets for cancer. Here we give a review of how PPARγ and its ligands regulate tumorigenesis by different pathways.</p>","PeriodicalId":19684,"journal":{"name":"Onkologie","volume":"36 10","pages":"598-601"},"PeriodicalIF":0.3000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000355328","citationCount":"30","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onkologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000355328","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/9/17 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 30

Abstract

The peroxisome proliferator-activated receptor-γ (PPARγ) belongs to the nuclear hormone receptor superfamily, and is expressed in adipose tissue, skeletal muscle, spleen, heart, liver, placenta, lung, and ovary. PPARγ is a critical regulator of inflammation, adipocyte differentiation, glucose homeostasis, and tumorigenesis. The mechanism of PPARγ on tumor suppression is still unclear, but plenty of evidence shows that PPARγ provides new therapeutic targets for cancer. Here we give a review of how PPARγ and its ligands regulate tumorigenesis by different pathways.

PPARγ通过不同的信号通路抑制肿瘤。
过氧化物酶体增殖物激活受体-γ (PPARγ)属于核激素受体超家族,在脂肪组织、骨骼肌、脾脏、心脏、肝脏、胎盘、肺和卵巢中表达。PPARγ是炎症、脂肪细胞分化、葡萄糖稳态和肿瘤发生的关键调节因子。PPARγ抑制肿瘤的机制尚不清楚,但大量证据表明,PPARγ为癌症提供了新的治疗靶点。在此,我们对PPARγ及其配体如何通过不同途径调节肿瘤发生进行综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Onkologie
Onkologie 医学-肿瘤学
CiteScore
0.40
自引率
33.30%
发文量
0
审稿时长
3 months
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信